MedPath

Bisoprolol

Generic Name
Bisoprolol
Brand Names
Ziac
Drug Type
Small Molecule
Chemical Formula
C18H31NO4
CAS Number
66722-44-9
Unique Ingredient Identifier
Y41JS2NL6U
Background

Bisoprolol is a cardioselective β1-adrenergic blocking agent used to treat high blood pressure. It is considered a potent drug with a long-half life that can be used once daily to reduce the need for multiple doses of antihypertensive drugs. Bisoprolol is generally well tolerated, likely due to its β1-adrenergic receptor selectivity and is a useful alternative to non-selective β-blocker drugs in the treatment of hypertension such as Carvedilol and Labetalol. It may be used alone or in combination with other drugs to manage hypertension and can be useful in patients with chronic obstructive pulmonary disease (COPD) due to its receptor selectivity.

Indication

Bisoprolol is indicated for the treatment of mild to moderate hypertension. It may be used off-label to treat heart failure, atrial fibrillation, and angina pectoris.

Associated Conditions
Atrial Fibrillation, Cardiovascular Events, Chronic Stable Angina Pectoris, Heart Failure, Hypertension, Mild Hypertension, Premature Ventricular Contraction (PVC), Supraventricular Arrhythmias, Moderate Hypertension, Perioperative arrhythmia

Treating Clozapine-induced Sinustachycardia With Bisoprolol

Not Applicable
Completed
Conditions
Clozapine-induced Sinustachycardia
Interventions
Drug: Placebo
First Posted Date
2009-04-17
Last Posted Date
2017-01-09
Lead Sponsor
University of Aarhus
Target Recruit Count
21
Registration Number
NCT00882856
Locations
🇩🇰

Aalborg University Hospital, Psychiatry, Aalborg, Denmark

Bisoprolol in Patients With Heart Failure and Chronic Obstructive Pulmonary Disease

Phase 2
Terminated
Conditions
Chronic Obstructive Pulmonary Disease
Heart Failure
Interventions
Drug: Placebo
First Posted Date
2008-06-20
Last Posted Date
2008-09-03
Lead Sponsor
NHS Greater Glasgow and Clyde
Target Recruit Count
27
Registration Number
NCT00702156
Locations
🇬🇧

Cardiopulmonary Transplant Unit Glasgow Royal Infirmary, Glasgow, Scotland, United Kingdom

Nt-proBNP Guided Primary Prevention of CV Events in Diabetic Patients

Phase 2
Completed
Conditions
Diabetes Mellitus
Heart Failure
Coronary Artery Disease
Interventions
First Posted Date
2007-11-26
Last Posted Date
2012-05-03
Lead Sponsor
Medical University of Vienna
Target Recruit Count
300
Registration Number
NCT00562952
Locations
🇦🇹

Medical University of Vienna, Vienna, Austria

🇦🇹

General Hospital of Vienna Department of Endocrinology, Vienna, Austria

Nebivolol Versus Bisoprolol Versus Carvedilol in Heart Failure

Phase 4
Completed
Conditions
Chronic Heart Failure
Interventions
First Posted Date
2007-08-17
Last Posted Date
2010-09-16
Lead Sponsor
Centro Cardiologico Monzino
Target Recruit Count
60
Registration Number
NCT00517725
Locations
🇮🇹

Centro Cardiologico Monzino, University of Milan, Milan, Italy

Evaluation of Heart Failure Treatment Guided by N-terminal Pro B-type Natriuretic Peptide (NTproBNP) vs Clinical Symptoms and Signs Alone

Phase 4
Completed
Conditions
Heart Failure
Ventricular Dysfunction, Left
Interventions
Drug: Diuretics
Drug: HF treatment according to Swedish guidelines
Procedure: Blood samples
Procedure: The Kansas City Cardiomyopathy Questionnaire (KCCQ)
First Posted Date
2006-10-25
Last Posted Date
2012-06-25
Lead Sponsor
AstraZeneca
Target Recruit Count
252
Registration Number
NCT00391846
Locations
🇸🇪

Research Site, Vaxjo, Sweden

Study to Investigate Effects of Antiischemic Drug Therapy in Silent Ischemia

Not Applicable
Completed
Conditions
Myocardial Ischemia
First Posted Date
2006-09-29
Last Posted Date
2006-10-12
Lead Sponsor
Luzerner Kantonsspital
Registration Number
NCT00382421
Locations
🇨🇭

Department of Cardiology, Hospital Lucerne, Lucerne, Switzerland

Chagas Cardiomyopathy Bisoprolol Intervention Study: Charity

Phase 3
Completed
Conditions
Chagas Cardiomyopathy
Chronic Heart Failure
Interventions
First Posted Date
2006-05-10
Last Posted Date
2010-11-24
Lead Sponsor
Fundación Cardiovascular de Colombia
Target Recruit Count
500
Registration Number
NCT00323973
Locations
🇨🇴

Fundación Cardiovascular de Colombia, Floridablanca, Santander, Colombia

© Copyright 2025. All Rights Reserved by MedPath